Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06863129 · ClinicalTrials.gov registry record · NA
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
A NA study of Metastatic Bone Disease, sponsored by Michelle Ghert, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 334
- Enrollment target
- 6
- Study locations
NCT06863129 is a NA study of Metastatic Bone Disease that is actively recruiting participants, run by Michelle Ghert, MD. The registered enrollment target is 334 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT06863129, a NA study of Metastatic Bone Disease, is actively recruiting participants, sponsored by Michelle Ghert, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 334 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are: 1. Does removing and replacing part of the bone work better than just stabilizing it with metal hardware? 2. Does removing and replacing the bone help reduce problems like cancer coming back or the metal hardware breaking? Researchers will compare two treatments: using metal rods and plates to stabilize the bone (internal fixation) versus removing part of the bone and possibly replacing the hip joint (resection and reconstruction) to see if the second option causes fewer problems. Participants will: * Be randomly assigned to one of two groups (internal fixation or resection and reconstruction). * Have one of the two surgeries based on which group they're in. * Go to follow-up appointments with the study doctor at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery.
Conditions Studied
Interventions
- PROCEDURE Internal Fixation
- PROCEDURE Resection and reconstruction
Study Locations (6)
Oregon
- Good Samaritan Regional Medical Center - Corvallis
- Oregon Health and Science University Hospital - Portland
Indiana
- Parkview Packnett Family Cancer Institute - Fort Wayne
Other
- Cliniques Universitaires Saint-Luc - Brussels
Rio Grande do Sul
- Hospital de Clínicas de Porto Alegre - Porto Alegre
To
- AOU Città della Salute e della Scienza CTO hospital - Torino
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06863129
The ClinicalTrials.gov registry entry for NCT06863129 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michelle Ghert, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Bone Disease appearing as the primary indexed condition, and to 2 interventions - of which Internal Fixation is the first listed.
NCT06863129 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Oregon, Indiana, Other.
Frequently Asked Questions
What is clinical trial NCT06863129 about?
NCT06863129 is a clinical study titled "Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial". The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are: 1. Does removing and replacing part of the bone work better than just st...
What is the current status of trial NCT06863129?
This trial is currently recruiting. It is a NA study. The enrollment target is 334 participants. The study started on 2025-02-01. Estimated completion is 2030-06-01.
What conditions does trial NCT06863129 study?
This clinical trial studies the following conditions: Metastatic Bone Disease.
What interventions are being tested in trial NCT06863129?
The interventions under investigation include: Internal Fixation (PROCEDURE), Resection and reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT06863129?
This trial is sponsored by Michelle Ghert, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06863129 being conducted?
This trial has 6 study locations across Indiana, Oregon, Rio Grande do Sul, To. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Bone Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.